Status Check: No, Centre Is NOT Sitting On Approvals To Other Vaccines
by Swarajya Staff - Apr 7, 2021 12:46 PM
Representative image (Unsplash)
Snapshot
India is following the standard approval process for all Covid-19 vaccines. No vaccine candidate s approval has been held back for arbitrary reasons.
Since the launch of the mass inoculation programme, Indian authorities have delivered over seven crore vaccines and earned global goodwill by exporting made-in-India shots to over 80 countries.
Indian drug regulators have so far given the green light to two vaccines â Covishield by the Oxford University-AstraZeneca collaboration, manufactured by Serum Institute of India (SII); and Covaxin by Indian biotechnology company Bharat Biotech.
03.01.21 Manage Field Service Efficiently And Safely During Challenging Times
Oxford Nano is providing innovative remote assistance through their Virtual Assist offering. Customers have instant access to their global team of service and applications experts to detect, help, and guide customers through technical and application issues in real time. All this is accomplished by using standard smart devices. Join us to hear from Dan Turner, global service business manager, on how he has assisted both staff and customers on this digital transformation and learn how he brought this vision to life.
By Paul Hesselschwerdt, Global Partners Training
Digital transformation of service is perhaps one of the most significant business trends to be accelerated by the COVID-19 pandemic. For most service providers, however, adoption had been slow and cautious.
Now, 179 COVID-19 testing kits available in India; about 40 indigenous
In the early days of COVID-19 outbreak last year, India relied on imports from leading medical companies like Roche Diagnostic, Korea s S.D Biosensor, Siemens Healthcare, Thermofisher, Abbott Healthcare, apart from Chinese and South Korean manufacturers
PB Jayakumar | February 23, 2021 | Updated 17:43 IST
Pune s Mylab was among the first to commercialise an indigenous testing kit in March, 2020
The Drug Controller General of India (DCGI) has approved 179 COVID-19 testing kits until mid-February. These testing kits include those produced by 30-40 Indian companies.
In the early days of COVID-19 outbreak last year, India relied on imports from leading medical companies like Roche Diagnostic, Korea s S.D Biosensor, Siemens Healthcare, Thermofisher, Abbott Healthcare, apart from Chinese and South Korean manufacturers.
IISC incubated start-up ShanMukha Innovations design ICMR approved COVID-19 mobile diagnostic lab
19 February 2021 | News Being the first of its kind, this mobile lab is fully equipped with BSL-2+ infrastructure and instruments including mini-spins, vortex mixers, centrifuge, pipettes, and RT-PCR to carry out sample collection, inactivation, RNA extraction and RT-PCR testing which is considered the gold standard for the detection of the coronavirus
IISc with support from United Way Bengaluru, an NGO and in partnership with corporate partners - global clinical research organisation Parexel International, State Street and Bharath Benz, have designed a mobile diagnostic lab – Nodal Hub. This is part of the 4-van series of which three vans were made ready in August 2020.